CD274 and lung carcinoma: HLA-A2+ lung cancer cell line, H441, was chosen as target lung cancer cells as H441 expressed a detectable level of PD-L1 proteins that were down-modulated by EGFR inhibitor (Fig 2A and Fig 5A).